CAJ | 학술논문

目的：：评价浙江省11家医院肺癌患者使用抗肿瘤中药康莱特注射液的应用状况,对其用药数据进行分析。方法：抽取浙江省11家医院2009~2013年肺癌患者每年40 d康莱特注射液的用药医嘱,统计使用康莱特注射液用药金额、用药频度( DDDs)、科室分布以及医保使用类别等利用情况。结果：11家医院肺癌患者的康莱特注射液使用金额呈逐年上升趋势,其中2011年和2012年增长较快,2012年是2009年的1.77倍；康莱特注射液使用金额占药品消耗总金额的比例先降后升；五年间,11家医院康莱特注射液使用金额排名前三位的科室为肿瘤科、放疗科、胸外科；康莱特注射液的用药量和DDDs,也呈逐年递增的趋势,以2011年和2012年增速较快。结论：浙江省11家医院肺癌患者使用康莱特注射液呈现持续快速增长势头,其在临床的合理化应用有待进一步加强。
목적：：평개절강성11가의원폐암환자사용항종류중약강래특주사액적응용상황,대기용약수거진행분석。방법：추취절강성11가의원2009~2013년폐암환자매년40 d강래특주사액적용약의촉,통계사용강래특주사액용약금액、용약빈도( DDDs)、과실분포이급의보사용유별등이용정황。결과：11가의원폐암환자적강래특주사액사용금액정축년상승추세,기중2011년화2012년증장교쾌,2012년시2009년적1.77배；강래특주사액사용금액점약품소모총금액적비례선강후승；오년간,11가의원강래특주사액사용금액배명전삼위적과실위종류과、방료과、흉외과；강래특주사액적용약량화DDDs,야정축년체증적추세,이2011년화2012년증속교쾌。결론：절강성11가의원폐암환자사용강래특주사액정현지속쾌속증장세두,기재림상적합이화응용유대진일보가강。
Objective:To evaluate the utilization of Kanglaite injections in lung cancer patients in 11 hospitals of Zhejiang and analyze the prescription data. Methods: Totally 40-day prescription data of the patients with lung cancer in 11 hospitals of Zhejiang were withdrawn every year from 2009 to 2013. The data in respect of the consumption sum, DDDs, department distribution and medical insurance category of Kanglaite injections were analyzed. Results: The consumption sum of Kanglaite injections used in the patients with lung cancer in 11 hospitals of Zhejiang showed an upward trend year by year, the growth in 2011 and 2012 was the fastest, and the sum in 2012 was 1. 77-fold of that in 2009. The consumption sum proportion of Kanglaite injections in total amount of drug consumption rose after the first drop. The top 3 departments were oncology, radiotherapy and thoracic surgery in the five years. The dosage and DDDs of Kanglaite injections were also in an increase trend year by year, and the growth in 2011 and 2012 was the fastest. Conclusion:The utilization of Kanglaite injections in the patients with lung cancer in Zhejiang area shows a continuous rapid growth momentum, therefore, it is still essential to strengthen the reasonable application in clinics.